Diego Centonze Selected Research

deoxynucleotidase

6/2022

Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Centonze Research Topics

Disease

108	Multiple Sclerosis 11/2022 - 04/2004
41	Inflammation (Inflammations) 10/2022 - 03/2009
24	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2002
23	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 10/2007
19	Relapsing-Remitting Multiple Sclerosis 09/2022 - 03/2012
13	Disease Progression 01/2022 - 03/2011
13	Neuroinflammatory Diseases 01/2021 - 01/2007
12	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2007
9	Huntington Disease (Huntington's Disease) 04/2017 - 01/2004
6	Pain (Aches) 01/2021 - 12/2009
6	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2007
6	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 03/2009
6	Dyskinesias (Dyskinesia) 10/2007 - 05/2003
5	COVID-19 01/2022 - 01/2021
5	Infections 01/2022 - 01/2018
5	Fatigue 10/2021 - 07/2011
5	Hypersensitivity (Allergy) 04/2021 - 07/2004
5	Parkinsonian Disorders (Parkinsonism) 07/2004 - 08/2002
4	Optic Neuritis (Retrobulbar Neuritis) 05/2022 - 01/2013
4	Cognitive Dysfunction 09/2019 - 02/2011
4	Progressive Multifocal Leukoencephalopathy 01/2018 - 08/2014
4	Schizophrenia (Dementia Praecox) 03/2011 - 09/2004
4	Ischemia 07/2006 - 01/2002
3	Narcolepsy 09/2022 - 01/2018
3	Neoplasms (Cancer) 01/2021 - 01/2017
3	Nervous System Diseases (Neurological Disorders) 01/2019 - 06/2014
3	Epilepsy (Aura) 01/2018 - 11/2012
3	Ischemic Stroke 10/2016 - 10/2007
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2010 - 01/2007
3	Substance-Related Disorders (Drug Abuse) 01/2010 - 08/2004
3	Infarction (Infarctions) 07/2007 - 12/2002
3	Brain Ischemia (Cerebral Ischemia) 05/2007 - 02/2003
2	Mood Disorders (Mood Disorder) 10/2022 - 09/2017
2	Sleepiness 09/2022 - 11/2020
2	Necrosis 11/2021 - 01/2019
2	Movement Disorders (Movement Disorder) 10/2021 - 01/2017
2	Disorders of Excessive Somnolence (Hypersomnia) 11/2020 - 01/2018
2	Anhedonia 01/2020 - 01/2018
2	Deglutition Disorders (Dysphagia) 10/2019 - 01/2019
2	Gliosis 01/2018 - 01/2016

Drug/Important Bio-Agent (IBA)

20	CytokinesIBA 01/2022 - 09/2011
19	EndocannabinoidsIBA 01/2020 - 08/2002
17	Glutamic Acid (Glutamate)FDA Link 12/2021 - 07/2004
14	CannabinoidsIBA 01/2022 - 01/2007
12	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2008
11	Natalizumab (Tysabri)FDA Link 01/2022 - 09/2010
10	Pharmaceutical PreparationsIBA 09/2022 - 10/2007
10	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 03/2015
9	Cladribine FDA LinkGeneric 11/2022 - 11/2013
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
9	Levodopa (L Dopa)FDA LinkGeneric 10/2007 - 12/2002
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2009
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 06/2005
7	InterferonsIBA 01/2022 - 03/2012
7	Dopamine (Intropin)FDA LinkGeneric 10/2021 - 08/2002
6	nabiximols (Sativex)IBA 01/2022 - 10/2009
6	Dimethyl FumarateIBA 06/2021 - 08/2015
5	nitazoxanide (NTZ)FDA Link 01/2022 - 08/2014
5	anandamide (arachidonylethanolamide)IBA 01/2020 - 08/2002
5	Dronabinol (THC)FDA LinkGeneric 01/2020 - 12/2009
5	Neuroprotective AgentsIBA 01/2018 - 02/2003
5	Interferon-betaIBA 01/2017 - 01/2014
5	Oxidopamine (6 Hydroxydopamine)IBA 04/2012 - 08/2002
4	TabletsIBA 11/2022 - 01/2020
4	EnzymesIBA 06/2022 - 11/2012
4	Retinaldehyde (Retinal)IBA 05/2022 - 01/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
4	ocrelizumabIBA 01/2022 - 04/2021
4	Biological ProductsIBA 01/2021 - 09/2017
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2013 - 02/2003
4	gamma-Aminobutyric Acid (GABA)IBA 11/2012 - 06/2005
3	Interleukin-2 (IL2)IBA 10/2022 - 09/2017
3	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 06/2013
3	Interferon beta-1a FDA Link 01/2021 - 07/2012
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	CannabidiolIBA 01/2020 - 12/2009
3	LipidsIBA 01/2020 - 11/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2003
3	Platelet-Derived Growth FactorIBA 04/2018 - 12/2013
3	PlasticsIBA 04/2017 - 04/2007
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2014 - 03/2011
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2008 - 01/2004
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022 - 04/2021
2	pitolisantIBA 09/2022 - 01/2018
2	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021 - 02/2015
2	VaccinesIBA 11/2021 - 07/2021
2	ProteomeIBA 01/2021 - 07/2015
2	D-Aspartic Acid (D Aspartate)IBA 01/2020 - 10/2008
2	InterleukinsIBA 01/2020 - 01/2019
2	Cholinergic Agents (Cholinergics)IBA 11/2019 - 05/2007
2	Apomorphine FDA Link 09/2019 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 05/2010
2	CuprizoneIBA 01/2019 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2018 - 06/2014
2	laquinimodIBA 01/2018 - 07/2013

Therapy/Procedure

21	Therapeutics 10/2022 - 07/2004
15	Transcranial Magnetic Stimulation 01/2022 - 04/2004
5	Injections 01/2021 - 07/2013
4	Transcranial Direct Current Stimulation 10/2019 - 05/2010
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2021 - 12/2014